Natural outcome of cannabis use disorder: A 3-year longitudinal follow-up

Addiction

Volumn 110, Issue 12, 2015, Pages 1963-1974

  Feingold, Daniel ^a,b   Fox, Jonah ^c   Rehm, Jürgen ^d,e   Lev Ran, Shaul ^b,c,d  

^a ARIEL UNIVERSITY   (Israel)

^b SHEBA MEDICAL CENTER   (Israel)

^c TEL AVIV UNIVERSITY   (Israel)

^d CENTRE FOR ADDICTION AND MENTAL HEALTH   (Canada)

^e UNIVERSITY OF TORONTO   (Canada)

Author keywords

Abuse; Cannabis use disorder; Dependence; Longitudinal follow up; NESARC; Non abstinent remission

Indexed keywords

ADULT; FEMALE; FOLLOW UP; HUMAN; LONGITUDINAL STUDY; MALE; MARIJUANA ABUSE; MIDDLE AGED; ONSET AGE; RECURRENT DISEASE; REMISSION; SOCIOECONOMICS; UNITED STATES; YOUNG ADULT;

ADULT; AGE OF ONSET; FEMALE; FOLLOW-UP STUDIES; HUMANS; LONGITUDINAL STUDIES; MALE; MARIJUANA ABUSE; MIDDLE AGED; RECURRENCE; REMISSION INDUCTION; REMISSION, SPONTANEOUS; SOCIOECONOMIC FACTORS; UNITED STATES; YOUNG ADULT;

EID: 84947036667     PISSN: 09652140     EISSN: 13600443     Source Type: Journal    
DOI: 10.1111/add.13071     Document Type: Article

References (51)

1. Degenhardt L., Bucello C., Calabria B., Nelson P., Roberts A., Hall W., et al. What data are available on the extent of illicit drug use and dependence globally? Results of four systematic reviews. Drug Alcohol Depend 2011; 117: 85-101.
2. Degenhardt L., Hall W. Extent of illicit drug use and dependence, and their contribution to the global burden of disease. Lancet 2012; 379: 55-70.
3. Substance Abuse and Mental Health Services Administration (SAMHSA) Results from the 2002 National Survey on Drug Use and Health: National Findings, Office of Applied Studies. Rockville, MD: Substance Abuse and Mental Health Services Administration; 2014.
4. Heiman G. A., Ogburn E., Gorroochurn P., Keyes K. M., Hasin D. Evidence for a two-stage model of dependence using the NESARC and its implications for genetic association studies. Drug Alcohol Depend 2008; 92: 258-66.
5. Lev-Ran S., Imtiaz S., Rehm J., Le Foll B. Exploring the association between lifetime prevalence of mental illness and transition from substance use to substance use disorders: results from the national epidemiologic survey of alcohol and related conditions (NESARC). Am J Addict 2013; 22: 93-8.
6. Chen C.-Y., O'Brien M. S., Anthony J. C. Who becomes cannabis dependent soon after onset of use? epidemiological evidence from the United States: 2000-2001. Drug Alcohol Depend 2005; 79: 11-22.
7. Compton W. M., Grant B. F., Colliver J. D., Glantz M. D., Stinson F. S. Prevalence of marijuana use disorders in the United States: 1991-1992 and 2001-2002. JAMA 2004; 291: 2114-21.
8. Whiteford H. A., Degenhardt L., Rehm J., Baxter A. J., Ferrari A. J., Erskine H. E., et al. Global burden of disease attributable to mental and substance use disorders: findings from the global burden of disease study 2010. Lancet 2013; 382: 1575-86.
9. Sidney S., Beck J. E., Tekawa I. S., Quesenberry C. P., Friedman G. D. Marijuana use and mortality. Am J Public Health 1997; 87: 585-90.
10. Mukamal K. J., Maclure M., Muller J. E., Mittleman M. A. An exploratory prospective study of marijuana use and mortality following acute myocardial infarction. Am Heart J 2008; 155: 465-70.
11. Calabria B., Degenhardt L., Hall W., Lynskey M. Does cannabis use increase the risk of death? systematic review of epidemiological evidence on adverse effects of cannabis use. Drug Alcohol Rev 2010; 29: 318-30.
12. Hooper S., Woolley D., De Bellis M. Intellectual, neurocognitive, and academic achievement in abstinent adolescents with cannabis use disorder. Psychopharmacology (Berl) 2014; 231: 1467-77.
13. McHale S., Hunt N. Executive function deficits in short-term abstinent cannabis users. Hum Psychopharmacol Clin Exp 2008; 23: 409-15.
14. Hanson K. L., Winward J. L., Schweinsburg A. D., Medina K. L., Brown S. A., Tapert S. F. Longitudinal study of cognition among adolescent marijuana users over three weeks of abstinence. Addict Behav 2010; 35: 970-6.
15. Fontes M. A., Bolla K. I., Cunha P. J., Almeida P. P., Jungerman F., Laranjeira R. R., et al. Frontal Assessment Battery (FAB) is a simple tool for detecting executive deficits in chronic cannabis users. J Clin Exp Neuropsychol 2011; 33: 523-31.
16. Schreiner A. M., Dunn M. E. Residual effects of cannabis use on neurocognitive performance after prolonged abstinence: a meta-analysis. Exp Clin Psychopharmacol 2012; 20: 420-9.
17. Crean R. D., Crane N. A., Mason B. J. An evidence based review of acute and long-term effects of cannabis use on executive cognitive functions. J Addict Med 2011; 5: 1-8.
18. Betty Ford Institute Consensus Panel What is recovery? A working definition from the Betty Ford Institute. J Subst Abuse Treat 2007; 33: 221-8.
19. American Psychiatric Association Diagnostic and Statistical Manual of Mental Disorders, 4thtext revision (DSM-IV-TR) edn. Washington, DC: American Psychiatric Association; 2000.
20. White W. L. Addiction recovery: its definition and conceptual boundaries. J Subst Abuse Treat 2007; 33: 229-41.
21. Lopez-Quintero C., Hasin D. S., de los Cobos J. P., Pines A., Wang S., Grant B. F., et al. Probability and predictors of remission from life-time nicotine, alcohol, cannabis or cocaine dependence: results from the national epidemiologic survey on alcohol and related conditions. Addiction 2011; 106: 657-69.
22. von Sydow K., Lieb R., Pfister H., Höfler M., Sonntag H., Wittchen H.-U. The natural course of cannabis use, abuse and dependence over four years: a longitudinal community study of adolescents and young adults. Drug Alcohol Depend 2001; 64: 347-61.
23. Gilder D. A., Lau P., Corey L., Ehlers C. L. Factors associated with remission from cannabis dependence in southwest California Indians. J Addict Dis 2007; 26: 23-30.
24. Perkonigg A., Goodwin R. D., Fiedler A., Behrendt S., Beesdo K., Lieb R., et al. The natural course of cannabis use, abuse and dependence during the first decades of life. Addiction 2008; 103: 439-49discussion 450-1.
25. Agrawal A., Lynskey M. T., Bucholz K. K., Kapoor M., Almasy L., Dick D. M., et al. DSM-5 cannabis use disorder: a phenotypic and genomic perspective. Drug Alcohol Depend 2014; 134: 362-9.
26. Mewton L., Slade T., Teesson M. An evaluation of the proposed DSM-5 cannabis use disorder criteria using Australian national survey data. J Stud Alcohol Drugs 2013; 74: 614-21.
27. Kelly S. M., Gryczynski J., Mitchell S. G., Kirk A., O'Grady K. E., Schwartz R. P. Concordance between DSM-5 and DSM-IV nicotine, alcohol, and cannabis use disorder diagnoses among pediatric patients. Drug Alcohol Depend 2014; 140: 213-6.
28. Farmer R. F., Kosty D. B., Seeley J. R., Duncan S. C., Lynskey M. T., Rohde P., et al. Natural course of cannabis use disorders. Psychol Med 2014; 45: 63-72.
29. Dawson D. A., Grant B. F., Stinson F. S., Chou P. S., Huang B., Ruan W. J. Recovery from DSM-IV alcohol dependence: United States, 2001-2002. Addiction 2005; 100: 281-92.
30. Dawson D. A., Goldstein R. B., Ruan W. J., Grant B. F. Correlates of recovery from alcohol dependence: a prospective study over a 3-year follow-up interval. Alcohol Clin Exp Res 2012; 36: 1268-77.
31. Swift W., Hall W., Teesson M. Cannabis use and dependence among Australian adults: results from the National Survey Of Mental Health And Wellbeing. Addiction 2001; 96: 737-48.
32. Clark D. B., Kirisci L., Tarter R. E. Adolescent versus adult onset and the development of substance use disorders in males. Drug Alcohol Depend 1998; 49: 115-21.
33. Grant B. F., Chou S. P., Goldstein R. B., Huang B., Stinson F. S., Saha T. D., et al. Prevalence, correlates, disability, and comorbidity of DSM-IV borderline personality disorder: results from the wave 2 National Epidemiologic Survey On Alcohol And Related Conditions. J Clin Psychiatry 2008; 69: 533-45.
34. Bernardi S., Faraone S. V., Cortese S., Kerridge B. T., Pallanti S., Wang S., et al. The lifetime impact of attention deficit hyperactivity disorder: results from the National Epidemiologic Survey on Alcohol and Related Conditions (NESARC). Psychol Med 2012; 42: 875-87.
35. Grant B., Goldstein R., Chou S., Huang B., Stinson F., Dawson D., et al. Sociodemographic and psychopathologic predictors of first incidence of DSM-IV substance use, mood and anxiety disorders: results from the wave 2 National Epidemiologic Survey On Alcohol And Related Conditions. Mol Psychiatry 2009; 14: 1051-66.
36. Grant B. F., Dawson D. A., Stinson F. S., Chou P. S., Kay W., Pickering R. The Alcohol Use Disorder And Associated Disabilities Interview Schedule-IV (AUDADIS-IV): reliability of alcohol consumption, tobacco use, family history of depression and psychiatric diagnostic modules in a general population sample. Drug Alcohol Depend 2003; 71: 7-16.
37. Beseler C. L., Hasin D. S. Cannabis dimensionality: dependence, abuse and consumption. Addict Behav 2010; 35: 961-9.
38. Hartman C. A., Gelhorn H., Crowley T. J., Sakai J. T., Stallings M., Young S. E., et al. Item response theory analysis of DSM-IV cannabis abuse and dependence criteria in adolescents. J Am Acad Child Adolesc Psychiatry 2008; 47: 165-73.
39. Research Triangle Institute R Software for Survey Data Analysis (SUDAAN), version 9.0. Research Triangle Park, NC: Research Triangle Institute; 2004.
40. Calabria B., Degenhardt L., Briegleb C., Vos T., Hall W., Lynskey M., et al. Systematic review of prospective studies investigating 'remission' from amphetamine, cannabis, cocaine or opioid dependence. Addict Behav 2010; 35: 741-9.
41. Tashkin D. P. Cannabis effects on the respiratory system. In: Kalant H., Corrigall W., Hall W., Smart R., editors. The Health Effects of Cannabis. Toronto: Centre for Addiction and Medicine; 1999, pp. 313-47.
42. Moore T. H., Zammit S., Lingford-Hughes A., Barnes T. R., Jones P. B., Burke M., et al. Cannabis use and risk of psychotic or affective mental health outcomes: a systematic review. Lancet 2007; 370: 319-28.
43. Stetser M., Shepherd J., Moore T. F. Using the census 2000/2001 supplementary survey as a sampling frame for the national epidemiologic survey on alcohol and related conditions, Joint Statistical Meetings - Section on Survey Research Methods; 2002. Available at: http://www.amstat.org/sections/srms/proceedings/y2002f.html (accessed 12August 2008).
44. Wittchen H. U., Frohlich C., Behrendt S., Gunther A., Rehm J., Zimmermann P., et al. Cannabis use and cannabis use disorders and their relationship to mental disorders: a 10-year prospective-longitudinal community study in adolescents. Drug Alcohol Depend 2007; 88: S60-70.
45. Lev-Ran S., Le Foll B., McKenzie K., George T. P., Rehm J. Cannabis use and cannabis use disorders among individuals with mental illness. Compr Psychiatry 2013; 54: 589-98.
46. Grucza R. A., Abbacchi A. M., Przybeck T. R., Gfroerer J. C. Discrepancies in estimates of prevalence and correlates of substance use and disorders between two national surveys. Addiction 2007; 102: 623-9.
47. Nelson C. B., Rehm J., Ustun T. B., Grant B., Chatterji S. Factor structures for DSM-IV substance disorder criteria endorsed by alcohol, cannabis, cocaine and opiate users: results from the WHO reliability and validity study. Addiction 1999; 94: 843-55.
48. Hasin D., Grant B. F., Cottler L., Blaine J., Towle L., Ustun B., et al. Nosological comparisons of alcohol and drug diagnoses: a multisite, multi-instrument international study. Drug Alcohol Depend 1997; 47: 217-26.
49. Culverhouse R., Bucholz K. K., Crowe R. R., Hesselbrock V., Nurnberger J. I. Jr., Porjesz B., et al. Long-term stability of alcohol and other substance dependence diagnoses and habitual smoking: an evaluation after 5years. Arch Gen Psychiatry 2005; 62: 753-60.
50. Fendrich M. The undeniable problem of recanting. Addiction 2005; 100: 143-4.
51. Morgan C. J., Curran H. V. Effects of cannabidiol on schizophrenia-like symptoms in people who use cannabis. Br J Psychiatry 2008; 192: 306-7.